American Healthcare REIT, Inc. (AHR) AI Stock Analysis

• Market Cap: $9.03B
• Dividend Yield: 2.1%
• Average Volume (3M): 2.23M
• Price to Earnings (P/E): 341.8
• Beta (1Y): 0.60
• Revenue Growth: 11.81%
• EPS Growth: N/A
• Country: US
• Employees: 114
• Sector: Real Estate
• Sector Strength: 53
• Industry: REIT - Healthcare Facilities
• EPS (TTM): 0.33
• Shares Outstanding: 185,511,050
• 10 Day Avg. Volume: 2,312,136
• 30 Day Avg. Volume: 2,228,822
• PEG Ratio: 1.34
• Price to Book (P/B): 1.64
• Price to Sales (P/S): 1.79
• P/FCF Ratio: 44.12
• Enterprise Value/Market Cap: 0.96
• Enterprise Value/Revenue: 3.95
• Enterprise Value/Gross Profit: 19.09
• Enterprise Value/Ebitda: 29.69
• 1Y Price Target: $55.36
• Price Target Upside: 15.02% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 11
• EPS Forecast (FY): 0.49
• Revenue Forecast (FY): $2.25B

• Rating: 64 Neutral
• Price Target: $51.00 ▲(5.96% Upside)

American Healthcare REIT, Inc. shows strong cash flow management and strategic growth initiatives, as highlighted in the earnings call and corporate events. However, profitability challenges and high valuation concerns weigh on the overall score. The stock's technical indicators suggest a balanced outlook, with moderate bullish momentum.

Positive Factors

Revenue Growth

Consistent revenue growth indicates a stable demand for healthcare facilities, supporting long-term business sustainability and expansion.

Cash Flow Management

Strong cash generation enhances financial flexibility, allowing for reinvestment in growth opportunities and debt reduction.

Strategic Acquisitions

Strategic acquisitions expand the portfolio and market presence, driving revenue and NOI growth, and enhancing competitive positioning.

Negative Factors

Profitability Concerns

Low profitability indicates challenges in cost management and pricing power, potentially limiting reinvestment and shareholder returns.

Medicare Rate Growth Challenges

Slower Medicare rate growth may impact revenue from healthcare facilities, posing a risk to future financial performance.

Seasonality Impact

Potential seasonal impacts on occupancy could affect revenue stability, challenging the company's ability to maintain growth momentum.

American Healthcare REIT, Inc. Business Overview & Revenue Model

Company Description

American Healthcare REIT, Inc. (AHR) is a real estate investment trust (REIT) that focuses on acquiring, owning, and managing healthcare-related properties across the United States. The company primarily operates in sectors such as senior housing, medical office buildings, and skilled nursing facilities. AHR's core services include leasing and property management, providing a diversified portfolio that caters to the growing demand for healthcare services.

How the Company Makes Money

AHR generates revenue primarily through rental income from its portfolio of healthcare properties leased to various tenants, including healthcare providers and operators. The company's revenue model is based on long-term leases, which typically provide stable and predictable cash flows. Key revenue streams include base rental payments, percentage rents, and reimbursement for property operating expenses. Additionally, AHR may benefit from property appreciation and strategic acquisitions. Partnerships with healthcare operators and providers can enhance occupancy rates and tenant stability, further contributing to its earnings.

American Healthcare REIT, Inc. Financial Statement Overview

Summary

American Healthcare REIT, Inc. demonstrates a mixed financial performance. Revenue growth is steady, and cash flow metrics are strong, indicating good operational cash management. However, profitability remains a concern with negative net income and return on equity. The company has improved its leverage position, but further efforts are needed to enhance profitability and shareholder returns.

Income Statement

The income statement shows a mixed performance. The TTM revenue growth rate is positive at 1.8%, indicating a steady increase in revenue. However, the company is struggling with profitability, as evidenced by a negative net profit margin of -1.53% and a negative net income. The gross profit margin has improved significantly to 39.85% in the TTM, suggesting better cost management. EBIT and EBITDA margins are moderate, indicating operational efficiency but not translating into net profitability.

Balance Sheet

The balance sheet reflects a moderate financial position. The debt-to-equity ratio has improved to 0.66 in the TTM, indicating a reduction in leverage compared to previous years. However, the return on equity remains negative at -1.43%, highlighting ongoing profitability challenges. The equity ratio is stable, suggesting a balanced asset structure, but the company needs to improve its return metrics to enhance shareholder value.

Cash Flow

Cash flow analysis shows positive trends, with a strong free cash flow growth rate of 34.63% in the TTM, indicating improved cash generation capabilities. The operating cash flow to net income ratio is high at 0.93, suggesting efficient cash conversion from operations. The free cash flow to net income ratio is also robust at 0.79, reflecting good cash flow management despite negative net income.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.20B	2.07B	1.86B	1.62B	1.26B	1.18B
Gross Profit	454.97M	416.77M	356.83M	335.97M	182.01M	158.58M
EBITDA	292.57M	315.48M	324.26M	233.76M	159.43M	165.14M
Net Income	27.26M	-37.81M	-71.47M	-81.30M	-47.79M	2.16M
Balance Sheet
Total Assets	4.77B	4.49B	4.58B	4.79B	4.58B	3.23B
Cash, Cash Equivalents and Short-Term Investments	147.36M	76.70M	43.45M	65.05M	81.60M	113.21M
Total Debt	1.70B	1.87B	3.02B	2.83B	2.50B	1.88B
Total Liabilities	2.05B	2.18B	3.12B	3.14B	2.75B	2.16B
Stockholders Equity	2.68B	2.26B	1.27B	1.40B	1.58B	866.11M
Cash Flow
Free Cash Flow	269.10M	84.15M	-1.26M	76.25M	-61.78M	90.85M
Operating Cash Flow	298.79M	176.09M	98.53M	147.77M	17.91M	219.16M
Investing Cash Flow	-286.11M	-8.73M	9.40M	-118.58M	-138.65M	-147.94M
Financing Cash Flow	55.06M	-134.74M	-129.06M	-42.92M	94.11M	-8.81M

American Healthcare REIT, Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 48.13
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AHR, the sentiment is Positive. The current price of 48.13 is below the 20-day moving average (MA) of 48.89, above the 50-day MA of 46.89, and above the 200-day MA of 38.57, indicating a neutral trend. The MACD of 0.05 indicates Positive momentum. The RSI at 50.47 is Neutral, neither overbought nor oversold. The STOCH value of 37.58 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AHR.

American Healthcare REIT, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CTRE	80 Outperform	$8.11B	27.07	8.13%	3.56%	59.25%	88.37%
NHI	77 Outperform	$3.71B	24.54	10.87%	4.65%	8.04%	9.20%
SBRA	77 Outperform	$4.66B	25.70	6.29%	6.42%	8.12%	75.95%
OHI	76 Outperform	$12.99B	24.70	11.28%	6.10%	13.50%	31.56%
Sector *	65 Neutral	$2.17B	12.19	3.79%	4.94%	3.15%	1.96%
AHR	64 Neutral	$9.03B	341.83	1.12%	2.10%	11.81%	―
HR	56 Neutral	$5.92B	-15.92	-7.26%	6.53%	-6.59%	33.35%

American Healthcare REIT, Inc. Corporate Events

American Healthcare REIT Declares Q4 2025 Distribution

On December 16, 2025, American Healthcare REIT, Inc. announced that its board of directors declared a quarterly distribution of $0.25 per share for the fourth quarter of 2025, payable in cash on or about January 16, 2026, to shareholders of record as of December 31, 2025. This distribution reflects an annualized rate of $1.00 per share, indicating the company’s ongoing commitment to providing returns to its investors, which may enhance its attractiveness in the healthcare real estate investment sector.

American Healthcare REIT Completes Public Stock Offering

On November 24, 2025, American Healthcare REIT, Inc. completed a public offering of 8,100,000 shares of its common stock, with an additional 1,215,000 shares sold following the underwriter’s exercise of their option. The proceeds from these transactions are intended to be used for general corporate purposes, including potential future investments, enhancing the company’s operational capacity and market positioning.

American Healthcare REIT Closes Public Stock Offering

American Healthcare REIT, Inc. announced the closing of a public offering of 8,100,000 shares of its common stock on November 24, 2025. The company entered into an underwriting agreement with RBC Capital Markets, LLC and a forward sale agreement with an affiliate, intending to use the proceeds for general corporate purposes, including potential future investments. This move is part of a strategic effort to strengthen its financial position and support growth initiatives.

American Healthcare REIT Reports Strong Q3 2025 Results

On November 6, 2025, American Healthcare REIT, Inc. announced its third quarter 2025 results, highlighting a GAAP net income of $55.9 million and a 16.4% growth in Same-Store Net Operating Income compared to the same period in 2024. The company also reported significant acquisition activity, closing over $575 million in new acquisitions year-to-date, and increased its full-year 2025 guidance due to strong performance in its senior housing and integrated senior health campuses segments. The announcement reflects the company’s strategic growth and favorable market conditions, positioning it well for continued expansion and stakeholder value enhancement.